Neuropharmacology

Health

A new therapeutic avenue for treating insomnia

Insomnia is one of the major sleep problems with an estimated prevalence of 10 percent to 15 percent in the general population and 30 percent to 60 percent in the older population. Moreover, insomnia frequently co-occurs ...

Neuroscience

Intellectual pursuits may buffer the brain against addiction

Challenging the idea that addiction is hardwired in the brain, a new UC Berkeley study of mice suggests that even a short time spent in a stimulating learning environment can rewire the brain's reward system and buffer it ...

Neuroscience

Neuropeptide may aid targeted anxiety therapy

The targeted control of biochemical processes and neuronal signalling pathways using the messenger substance neuropeptide Y could help in the future treatment of anxiety disorders. This is demonstrated in research findings ...

Diseases, Conditions, Syndromes

Multi-mechanism approach to treating neonatal hypoxic ischemia

Hypothermia alone, the current standard of care, neuroprotects roughly 50 percent of newborns with moderate to severe hypoxic ischemia. Therefore, half of all affected newborns are left with developmental, cognitive and motor ...

page 2 from 6